Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-10-13
2008-10-21
Mosher, Mary E (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C424S228100, C424S189100, C930S230000, C422S256000
Reexamination Certificate
active
07439347
ABSTRACT:
Disclosed herein is the discovery of a novel hepatitis C virus (HCV) isolated from a human patient. Embodiments of the invention include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as, methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.
REFERENCES:
patent: 4215051 (1980-07-01), Schroeder et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4486530 (1984-12-01), David et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4818540 (1989-04-01), Chien et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4950647 (1990-08-01), Robins et al.
patent: 4965188 (1990-10-01), Mullis
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5290678 (1994-03-01), Jackowski
patent: 5322770 (1994-06-01), Gelfand
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5371017 (1994-12-01), Houghton et al.
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5412087 (1995-05-01), McGall et al.
patent: 5585258 (1996-12-01), Houghton et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5597691 (1997-01-01), Houghton et al.
patent: 5604105 (1997-02-01), Jackowski
patent: 5670152 (1997-09-01), Weiner et al.
patent: 5670153 (1997-09-01), Weiner et al.
patent: 5679342 (1997-10-01), Houghton et al.
patent: 5683864 (1997-11-01), Houghton et al.
patent: 5698390 (1997-12-01), Houghton et al.
patent: 5710008 (1998-01-01), Jackowski
patent: 5712087 (1998-01-01), Houghton et al.
patent: 5712088 (1998-01-01), Houghton et al.
patent: 5712145 (1998-01-01), Houghton et al.
patent: 5714596 (1998-02-01), Houghton et al.
patent: 5728520 (1998-03-01), Weiner et al.
patent: 5739118 (1998-04-01), Carrano et al.
patent: 5744358 (1998-04-01), Jackowski
patent: 5747274 (1998-05-01), Jackowski
patent: 5756312 (1998-05-01), Weiner et al.
patent: 5766845 (1998-06-01), Weiner et al.
patent: 5767097 (1998-06-01), Tam
patent: 5847101 (1998-12-01), Okayama et al.
patent: 5856437 (1999-01-01), Miyamura et al.
patent: 5863719 (1999-01-01), Houghton et al.
patent: 5871903 (1999-02-01), Miyamura et al.
patent: 5879904 (1999-03-01), Brechot et al.
patent: 5885799 (1999-03-01), Houghton et al.
patent: 5932556 (1999-08-01), Tam
patent: 5942234 (1999-08-01), Ralston et al.
patent: 5959092 (1999-09-01), Miyamura et al.
patent: 5968775 (1999-10-01), Houghton et al.
patent: 5989905 (1999-11-01), Houghton et al.
patent: 6027729 (2000-02-01), Houghton et al.
patent: 6056961 (2000-05-01), Lavie et al.
patent: 6060068 (2000-05-01), Doyle et al.
patent: 6063380 (2000-05-01), Chedid et al.
patent: 6063772 (2000-05-01), Tam
patent: 6071693 (2000-06-01), Cha et al.
patent: 6074816 (2000-06-01), Houghton et al.
patent: 6074846 (2000-06-01), Ralston et al.
patent: 6074852 (2000-06-01), Ralston et al.
patent: 6096541 (2000-08-01), Houghton et al.
patent: 6130326 (2000-10-01), Ramasamy et al.
patent: 6150087 (2000-11-01), Chien
patent: 6150337 (2000-11-01), Tam
patent: 6153421 (2000-11-01), Yanagi et al.
patent: 6171782 (2001-01-01), Houghton et al.
patent: 6190864 (2001-02-01), Cha et al.
patent: 6194140 (2001-02-01), Houghton et al.
patent: 6214583 (2001-04-01), Cha et al.
patent: 6235888 (2001-05-01), Pachuk et al.
patent: 6274148 (2001-08-01), Ralston et al.
patent: 6297370 (2001-10-01), Cha et al.
patent: 6303292 (2001-10-01), Weiner et al.
patent: 6312889 (2001-11-01), Houghton et al.
patent: 6514731 (2003-02-01), Valenzuela et al.
patent: 6541011 (2003-04-01), Punnonen et al.
patent: 6555114 (2003-04-01), Maertens et al.
patent: 6653125 (2003-11-01), Donnelly et al.
patent: 6680059 (2004-01-01), Sallberg et al.
patent: 6762024 (2004-07-01), Maertens et al.
patent: 6858590 (2005-02-01), Sallberg et al.
patent: 6960569 (2005-11-01), Sallberg
patent: 6974864 (2005-12-01), Maertens et al.
patent: 7056658 (2006-06-01), Valenzuela et al.
patent: 7105303 (2006-09-01), Ralston et al.
patent: 7122306 (2006-10-01), Maertens et al.
patent: 2002/0165172 (2002-11-01), Sallberg et al.
patent: 2002/0187945 (2002-12-01), Tam
patent: 2003/0007977 (2003-01-01), Wheeler et al.
patent: 2003/0008274 (2003-01-01), Maeterns et al.
patent: 2004/0092730 (2004-05-01), Sallberg
patent: 0 388 232 (1990-09-01), None
patent: 0 414 475 (1991-02-01), None
patent: 0 450 931 (1996-06-01), None
patent: 0 543 924 (1997-06-01), None
patent: 0 842 947 (1998-05-01), None
patent: 0 693 687 (1999-07-01), None
patent: 0 556 292 (1999-12-01), None
patent: 1 034 785 (2000-09-01), None
patent: 0 318 216 (2001-08-01), None
patent: 0 398 748 (2002-01-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 91/15575 (1991-10-01), None
patent: WO 92/10092 (1992-06-01), None
patent: WO 92/19743 (1992-11-01), None
patent: WO 93/00365 (1993-01-01), None
patent: WO 93/06126 (1993-04-01), None
patent: WO 94/11530 (1994-05-01), None
patent: WO 94/12305 (1994-06-01), None
patent: WO 94/16737 (1994-08-01), None
patent: WO 95/11995 (1995-05-01), None
patent: WO 96/09805 (1996-04-01), None
patent: WO 96/28162 (1996-09-01), None
patent: WO 96/33739 (1996-10-01), None
patent: WO 97/12043 (1997-04-01), None
patent: WO 97/26883 (1997-07-01), None
patent: WO 97/29212 (1997-08-01), None
patent: WO 97/31256 (1997-08-01), None
patent: WO 97/47358 (1997-12-01), None
patent: WO 98/16184 (1998-04-01), None
patent: WO 98/16186 (1998-04-01), None
patent: WO 98/30223 (1998-07-01), None
patent: WO 98/34640 (1998-08-01), None
patent: WO 98/37180 (1998-08-01), None
patent: WO 99/04008 (1999-01-01), None
patent: WO 99/28482 (1999-06-01), None
patent: WO 00/44388 (2000-08-01), None
patent: WO 01/38360 (2001-05-01), None
patent: WO 01/96875 (2001-12-01), None
patent: WO 02/13855 (2002-02-01), None
patent: WO 02/14362 (2002-02-01), None
patent: WO 03/031588 (2003-04-01), None
U.S. Appl. No. 08/008,342, filed Jan. 26, 1993, Weiner et al.
U.S. Appl. No. 08/029,336, filed Mar. 11, 1993, Weiner et al.
AASLD Abstracts 940, “Hepatitis C Virus NS5A Sequence Configuration does not Predict Response to Induction Interferon Plus Ribavinn,” Hepatology, p. 394A (2000).
Andre et al., “Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage,” Journal of Virology, 72(2):1497-1503 (1998).
Blastn 2.2.9., May 1, 2004.
Chen et al., “Detection of Hepatitis C Virus RNA in the Cell Fraction of Saliva Before and After Oral Surgery,” J. Med. Virol., 43:223-226 (1995).
Chen et al., “Human and Murine Antibody Recognition is Focused on the ATPase/Helicase, but not the Protease Domain of the Hepatitis C Virus Nonstructural 3 Protein,” Hepatalogy, 28(1):219-224 (1998).
Chiang at al., “Enhancement of hepatitis C Virus core antigen-specific type 1 T helper cell response by ribavirin correlates with the increased level of IL-2,” Vaccine Strategies Against Microbial Pathogens, 42.11-42.16, p. A949 Apr. 20, 2000.
Cotonat et al., “Pilot Study of Combination Therapy with Ribavirin and Interferon Alfa for the Retreatment of Chronic Hepatitis B e Antibody-Positive Patients”, Hepatology, 31(2):502-506 (2000).
Cramp et al., “Hepatitis C Virus-Specific T-Cell Reactivity During Intereron and Ribavirin Treatment in Chronic Hepatitis C,” Gastron. Enterol., 118:346-355 (2000).
Database Genbank [Online] Dec. 2, 1994, retrieved from NCBI Database accession No. IO6434, XP002278035.
Database Registry [Online] No. 511600-20-7, XP02278058 abstract & WO 03/031588A, Apr. 17, 2003, Seq ID No. 1, 10 and 11 Claims.
Diepolder et al., “Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection,” Lancet, 346(8981):1006-1007.
Encke et al., “Genetic Immunization Generates Cellular and Humoral Immune Responses Against the Nonstructural Proteins of the Hepatit
Knobbe Martens Olson & Bear LLP
Li Bao Qun
Mosher Mary E
Tripep AB
LandOfFree
Hepatitis C virus non-structural NS3/4A fusion gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus non-structural NS3/4A fusion gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus non-structural NS3/4A fusion gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012466